BRPI1007186A2 - composto, composição farmacêutica, e, uso de um composto - Google Patents
composto, composição farmacêutica, e, uso de um compostoInfo
- Publication number
- BRPI1007186A2 BRPI1007186A2 BRPI1007186A BRPI1007186A BRPI1007186A2 BR PI1007186 A2 BRPI1007186 A2 BR PI1007186A2 BR PI1007186 A BRPI1007186 A BR PI1007186A BR PI1007186 A BRPI1007186 A BR PI1007186A BR PI1007186 A2 BRPI1007186 A2 BR PI1007186A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009008635 | 2009-01-19 | ||
PCT/JP2010/050221 WO2010082563A1 (ja) | 2009-01-19 | 2010-01-12 | ヘテロ原子を有する環状化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1007186A2 true BRPI1007186A2 (pt) | 2016-02-23 |
Family
ID=42339816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1007186A BRPI1007186A2 (pt) | 2009-01-19 | 2010-01-12 | composto, composição farmacêutica, e, uso de um composto |
Country Status (18)
Country | Link |
---|---|
US (1) | US8685981B2 (pt) |
EP (1) | EP2380878B1 (pt) |
JP (1) | JP5630868B2 (pt) |
KR (1) | KR20110110183A (pt) |
CN (1) | CN102325754B (pt) |
AU (1) | AU2010205239B2 (pt) |
BR (1) | BRPI1007186A2 (pt) |
CA (1) | CA2749114C (pt) |
CO (1) | CO6420338A2 (pt) |
ES (1) | ES2431824T3 (pt) |
IL (1) | IL213997A0 (pt) |
MX (1) | MX2011007543A (pt) |
NZ (1) | NZ593996A (pt) |
RU (1) | RU2011134637A (pt) |
SG (1) | SG172800A1 (pt) |
TW (1) | TW201030003A (pt) |
WO (1) | WO2010082563A1 (pt) |
ZA (1) | ZA201104717B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090312321A1 (en) * | 2006-05-15 | 2009-12-17 | Irm Llc | Compositions and methods for fgf receptor kinases inhibitors |
JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
KR20150085538A (ko) | 2012-11-20 | 2015-07-23 | 에프. 호프만-라 로슈 아게 | 치환된 1,6-나프티리딘 |
CA2911156A1 (en) * | 2013-05-03 | 2014-11-06 | F. Hoffmann-La Roche Ag | Neurogenesis-stimulating isoquinoline derivatives |
CN104788450A (zh) * | 2015-04-23 | 2015-07-22 | 湖南华腾制药有限公司 | 一种吡啶并哌嗪衍生物的制备方法 |
IL300572A (en) | 2018-02-13 | 2023-04-01 | Gilead Sciences Inc | PD–1/PD–L1 inhibitors |
JP7242702B2 (ja) | 2018-04-19 | 2023-03-20 | ギリアード サイエンシーズ, インコーポレイテッド | Pd-1/pd-l1阻害剤 |
PT3820572T (pt) | 2018-07-13 | 2023-11-10 | Gilead Sciences Inc | Inibidores pd-1/pd-l1 |
AU2019366355B2 (en) | 2018-10-24 | 2022-10-13 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
CN115181091A (zh) * | 2022-06-21 | 2022-10-14 | 江苏联环药业股份有限公司 | 一种贝他斯汀的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW403757B (en) | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
JPH09188665A (ja) | 1996-01-05 | 1997-07-22 | Kyorin Pharmaceut Co Ltd | 新規置換n−キノリルアントラニル酸誘導体及びその製造法 |
MXPA03010679A (es) | 2001-05-23 | 2004-03-02 | Tanabe Seiyaku Co | Una composicion para acelerar la cicatrizacion de fractura osea. |
WO2002100405A1 (en) * | 2001-06-11 | 2002-12-19 | Vertex Pharmaceuticals Incorporated | Isoquinoline inhibitors of p38 |
US20050096322A1 (en) | 2002-03-01 | 2005-05-05 | Susumu Igarashi | Nitrogen-containing heterocyclic compound |
JP4385620B2 (ja) * | 2002-03-01 | 2009-12-16 | アステラス製薬株式会社 | 含窒素複素環化合物 |
US7282506B2 (en) * | 2004-08-03 | 2007-10-16 | Serenex, Inc. | 2,8-disubstituted naphthyridine derivatives |
GB0516723D0 (en) * | 2005-08-15 | 2005-09-21 | Novartis Ag | Organic compounds |
JP2007131617A (ja) | 2005-10-11 | 2007-05-31 | Sankyo Co Ltd | チエノピリジン誘導体を含有する医薬 |
-
2010
- 2010-01-12 CN CN201080008829.6A patent/CN102325754B/zh not_active Expired - Fee Related
- 2010-01-12 EP EP10731232.4A patent/EP2380878B1/en not_active Not-in-force
- 2010-01-12 MX MX2011007543A patent/MX2011007543A/es not_active Application Discontinuation
- 2010-01-12 NZ NZ593996A patent/NZ593996A/xx not_active IP Right Cessation
- 2010-01-12 JP JP2010546620A patent/JP5630868B2/ja not_active Expired - Fee Related
- 2010-01-12 BR BRPI1007186A patent/BRPI1007186A2/pt not_active IP Right Cessation
- 2010-01-12 SG SG2011047404A patent/SG172800A1/en unknown
- 2010-01-12 CA CA2749114A patent/CA2749114C/en not_active Expired - Fee Related
- 2010-01-12 ES ES10731232T patent/ES2431824T3/es active Active
- 2010-01-12 AU AU2010205239A patent/AU2010205239B2/en not_active Ceased
- 2010-01-12 KR KR1020117016317A patent/KR20110110183A/ko not_active Application Discontinuation
- 2010-01-12 WO PCT/JP2010/050221 patent/WO2010082563A1/ja active Application Filing
- 2010-01-12 RU RU2011134637/04A patent/RU2011134637A/ru not_active Application Discontinuation
- 2010-01-18 TW TW099101206A patent/TW201030003A/zh unknown
-
2011
- 2011-06-24 ZA ZA2011/04717A patent/ZA201104717B/en unknown
- 2011-07-07 IL IL213997A patent/IL213997A0/en unknown
- 2011-07-14 US US13/182,777 patent/US8685981B2/en not_active Expired - Fee Related
- 2011-08-11 CO CO11102287A patent/CO6420338A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2749114A1 (en) | 2010-07-22 |
TW201030003A (en) | 2010-08-16 |
EP2380878A4 (en) | 2012-06-13 |
NZ593996A (en) | 2012-10-26 |
ES2431824T3 (es) | 2013-11-28 |
ZA201104717B (en) | 2012-03-28 |
CO6420338A2 (es) | 2012-04-16 |
JP5630868B2 (ja) | 2014-11-26 |
IL213997A0 (en) | 2011-08-31 |
SG172800A1 (en) | 2011-08-29 |
EP2380878B1 (en) | 2013-08-14 |
CN102325754A (zh) | 2012-01-18 |
MX2011007543A (es) | 2011-09-06 |
AU2010205239A1 (en) | 2011-08-04 |
KR20110110183A (ko) | 2011-10-06 |
JPWO2010082563A1 (ja) | 2012-07-05 |
CA2749114C (en) | 2013-12-17 |
US20110269746A1 (en) | 2011-11-03 |
WO2010082563A1 (ja) | 2010-07-22 |
US8685981B2 (en) | 2014-04-01 |
CN102325754B (zh) | 2014-03-12 |
RU2011134637A (ru) | 2013-02-27 |
EP2380878A1 (en) | 2011-10-26 |
AU2010205239B2 (en) | 2012-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
BRPI0810696A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BR112014001255A2 (pt) | composto, uso de um composto, combinação, e, composição farmacêutica | |
BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BRPI0918360A2 (pt) | composto, composição farmacêutica e usos de um composto | |
BRPI0810161A2 (pt) | Composto, preparação farmacêutica, composição farmacêutica, e, uso de um composto | |
BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0915134A2 (pt) | composto, e, uso de um composto | |
BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
BRPI1007186A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BRPI0810019A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
BRPI0919165A2 (pt) | composição farmacêutica,e, uso de um composto | |
BRPI0915473A2 (pt) | composto, composição farmacêutica, e, uso de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |